Ionix Pharmaceuticals Company

A leader in the discovery and development of new analgesic medicines for the treatment of acute and chronic pain.

Last Funding Type: Series A
Funding Status: M&A
Headquarters: Cambridge, Cambridgeshire, United Kingdom
Founded Date: 2001
Investor Type: For Profit
Total Funding: $11M
Technology: Neurological Disorders
Employee Number: 101-250
Investors Number: 5
Industry: PharmTech